Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05283954 |
|
Recruitment Status :
Withdrawn
(Lack of funding)
First Posted : March 17, 2022
Last Update Posted : March 9, 2023
|
Sponsor:
Oriol Mitja
Collaborators:
National Department of Health, Papua New Guinea
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Information provided by (Responsible Party):
Oriol Mitja, Lihir Medical Centre
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | June 30, 2022 |
| Estimated Study Completion Date : | July 30, 2022 |